Understanding What Class of Drug Is Mirikizumab?
•
3 min read
In October 2023, the U.S. Food and Drug Administration (FDA) approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active ulcerative colitis in adults. Understanding what class of drug is mirikizumab reveals its targeted approach to treating inflammatory bowel diseases (IBD) by inhibiting a key pathway responsible for chronic inflammation.
